Why Psychedelic Harm Reduction?
Dr. med. Tomislav Majić
Photos
Abstract
Harm reduction is an approach in more recent drug research and therapy that is concerned with the health and social consequences of using addictive substances rather than with the goal of abstinence. Since psychedelics, although they are counted among the psychoactive substances, are generally not associated with the development of dependence, the term “psychedelic harm reduction” may not seem immediately self-evident. All the more so since, in the eyes of many users, psychedelics are considered harmless and safe. This lecture will address the possible risks and complications of psychedelics. Following a brief historical overview, a classification of psychedelic-related complications will be proposed that is based on the temporal dynamics of the substances’ effects.
Live only, in person and on Zoom – there will be no recording this time.
About the speaker
Dr. med. Tomislav Majić
Psychiatrist and psychotherapist at the Psychiatric University Hospital of Charité at St. Hedwig Hospital in Berlin, and co-head of the Psychedelic Substances Research Group at Charité. He heads a department of general psychiatry, an outpatient clinic for dual diagnosis and the “Ambulanz Psychedelische Substanzen”, an outpatient clinic treating patients with psychedelic-related disorders. He is a researcher and study therapist in trials investigating psychedelic-assisted therapy, editor of the volume “Psychedelic Harm Reduction”, and a lecturer at the Berlin Institute for Psychotherapy and Psychoanalysis.
In cooperation with

A joint lecture by the PSNG and the BPSA.
Further reading
- When
- Wednesday, 4 November 2026
- 19:00 – 20:30
- Where
- Zoom and in person at HU Berlin
In numbers
- attendees
- 61
- of which online
- 46

